Back to Top Skip to main content Skip to sub-navigation

U.S. continues sending medical supplies to India for COVID-19 fight

A picture of a C-5M Super Galaxy Airmen from the 22nd Airlift Squadron prepare a C-5M Super Galaxy to take lifesaving COVID-19 supplies from Travis Air Force Base, Calif., to India, April 28, 2021 (Photo by: Nicholas Pilch, US Air Force).

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

A lot of progress has been made against COVID-19, but it's still a global pandemic. As part of a whole-of-government effort to slow and eventually end the pandemic, the United States is sending medical supplies and equipment to India as that country battles the most recent outbreak.

Last week, a C-5M Super Galaxy aircraft loaded with oxygen cylinders and regulators, N95 masks and COVID-19 rapid diagnostic kits left Travis Air Force Base, California, bound for India. Wednesday's shipment was just the first. In all, the United States expects to deliver more than $100 million in medical supplies to the U.S. partner nation. Thursday morning, a C-17 Globemaster III departed Travis for India carrying additional oxygen cylinders and diagnostic kits.

The medical supplies were donated to India by the U.S. government though the U.S. Agency for International Development. Airmen with the 60th Air Mobility Wing are responsible for delivering those supplies.

In the coming week, more oxygen cylinders will be sent, as will oxygen concentrators, oxygen generation units, additional personnel protective equipment, rapid diagnostic tests and therapeutics. The U.S. is also providing vaccine manufacturing supplies. In fact, the U.S. has redirected its own order of AstraZeneca manufacturing supplies to India, which will enable the country to make over 20 million doses of the COVID-19 vaccine.

A picture of COVID-19 supplies in a C-5M Super Galaxy
Oxygen cylinders and other COVID-19 supplies sit in a C-5M Super Galaxy at Travis Air Force Base, Calif., April 28, 2021 (Photo by: Air Force Senior Airman Jonathon Carnell).

India is a major defense partner to the United States and providing assistance is just something partners do, said Pentagon Press Secretary John F. Kirby during a press briefing earlier this week.

"The United States deeply values our partnership with India," Kirby said. "We are determined to help the people in India as they bravely combat this outbreak."

During a visit to India last month, Secretary of Defense Lloyd J. Austin III said India is a major partner in the effort to keep a free and open Indo-Pacific region.

"As the world faces a global pandemic and growing challenges to an open and stable international system, the U.S.-India relationship is a stronghold of a free and open Indo-Pacific region," he said. "And it's clear that the importance of this partnership, and its impact [on] the international, rules-based order will only grow in the years ahead."

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus
Showing results 1 - 10 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.